Literature DB >> 8504811

NMR and molecular modeling studies of the interaction of berenil and pentamidine with d(CGCAAATTTGCG)2.

T C Jenkins1, A N Lane, S Neidle, D G Brown.   

Abstract

The interaction of two anti-trypanosomal agents, berenil and pentamidine, with the A+T-rich dodecamer d(CGCAAATTTGCG)2 has been examined by high-resolution 1H-NMR, optical spectroscopy, and molecular modeling. Proton assignments for the free DNA and each DNA-ligand complex were obtained using nuclear Overhauser enhancement spectroscopy and total correlation spectroscopy. Complexation induces large changes in chemical shift for protons in the DNA minor groove for the A5-T9 segment, and intermolecular NOEs reveal contacts between the DNA bases and each ligand. The asymmetric binding site for berenil indicated by the NMR data suggests that at least two overlapping sites are involved. Rapid exchange between symmetrically-equivalent binding sites, via dissociative rearrangement, is consistent with retention of twofold degeneracy for both the ligand and the DNA host. Calculations of binding energy confirm that this DNA duplex contains overlapping sites of similar binding affinity. In contrast, the larger pentamidine molecule occupies a site that spans four or five bp, with asymmetric binding to the minor-groove 5'-ATTT sequence. The B-type conformation of the DNA is not altered substantially by either ligand.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504811     DOI: 10.1111/j.1432-1033.1993.tb17868.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  13 in total

1.  Hydration of the RNA duplex r(CGCAAAUUUGCG)2 determined by NMR.

Authors:  M R Conte; G L Conn; T Brown; A N Lane
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

2.  Conformational properties and thermodynamics of the RNA duplex r(CGCAAAUUUGCG)2: comparison with the DNA analogue d(CGCAAATTTGCG)2.

Authors:  M R Conte; G L Conn; T Brown; A N Lane
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

3.  Determination of receptor-bound drug conformations by QSAR using flexible fitting to derive a molecular similarity index.

Authors:  C A Montanari; M S Tute; A E Beezer; J C Mitchell
Journal:  J Comput Aided Mol Des       Date:  1996-02       Impact factor: 3.686

4.  The dependence of DNase I activity on the conformation of oligodeoxynucleotides.

Authors:  D H Sutton; G L Conn; T Brown; A N Lane
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

5.  Designer DNA-binding drugs: the crystal structure of a meta-hydroxy analogue of Hoechst 33258 bound to d(CGCGAATTCGCG)2.

Authors:  G R Clark; C J Squire; E J Gray; W Leupin; S Neidle
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

6.  Sequence-selective binding to DNA of bis(amidinophenoxy)alkanes related to propamidine and pentamidine.

Authors:  C Bailly; D Perrine; J C Lancelot; C Saturnino; M Robba; M J Waring
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

7.  Structure of a bis-amidinium derivative of hoechst 33258 complexed to dodecanucleotide d(CGCGAATTCGCG)2: the role of hydrogen bonding in minor groove drug-DNA recognition.

Authors:  G R Clark; D W Boykin; A Czarny; S Neidle
Journal:  Nucleic Acids Res       Date:  1997-04-15       Impact factor: 16.971

8.  Variability in DNA minor groove width recognised by ligand binding: the crystal structure of a bis-benzimidazole compound bound to the DNA duplex d(CGCGAATTCGCG)2.

Authors:  A A Wood; C M Nunn; A Czarny; D W Boykin; S Neidle
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

9.  Hydrogen bond geometry in DNA-minor groove binding drug complexes.

Authors:  L Tabernero; J Bella; C Alemán
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

10.  Site- and sequence-selective ultrafast hydration of DNA.

Authors:  Samir Kumar Pal; Liang Zhao; Tianbing Xia; Ahmed H Zewail
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.